DNA METHYLATION-BASED SUBCLASS PREDICTS THE EFFECT OF THE EXTENT OF RESECTION ON SURVIVAL IN IDH-WILDTYPE GLIOBLASTOMA

被引：0
|
作者：
Dankmeijer, L. G. [1 ,2 ]
Westerink, L. G. [1 ,2 ]
Hamer, P. C. de Witt [1 ,2 ]
Wesseling, P. [3 ,4 ]
Kouwenhoven, M. C. M. [5 ]
Kooi, E. [3 ]
Verburg, N. [1 ,2 ]
机构：
[1] Amsterdam UMC, Locat VUmc, Dept Neurosurg, Amsterdam, Netherlands
[2] Canc Ctr Amsterdam, Brain Tumor Ctr, Amsterdam, Netherlands
[3] Amsterdam UMC, Locat VUmc, Dept Pathol, Amsterdam, Netherlands
[4] Univ Med Ctr Utrecht, Dept Pathol, Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[5] Amsterdam UMC, Locat VUmc, Dept Neurol, Amsterdam, Netherlands
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad137.281
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P11.47.B
引用
收藏
页数：1
相关论文
共 50 条
  • [41] EXTENT, PATTERN, AND PROGNOSTIC VALUE OF MGMT PROMOTOR METHYLATION: DOES IT DIFFER BETWEEN GLIOBLASTOMA AND IDH-WILDTYPE/TERT-MUTATED ASTROCYTOMA?
    Teske, Nico
    Karschnia, Philipp
    Weller, Jonathan
    Siller, Sebastian
    Dorostkar, Mario M.
    Herms, Jochen
    von Baumgarten, Louisa
    Tonn, Joerg-Christian
    Thon, Niklas
    NEURO-ONCOLOGY, 2021, 23 : 122 - 122
  • [42] Supramarginal Resection Impact on Overall Survival for IDH-Wildtype Glioblastoma According to Their Cell Density Distribution and Infiltration Profile: A Mathematical Model
    Vivas-Buitrago, Tito
    Domingo, Ricardo
    Tripathi, Shashwat
    De Biase, Gaetano
    Ramos-Fresnedo, Andres
    Brown, Desmond A.
    Akinduro, Oluwaseun
    Sherman, Wendy
    Sabsevitz, David S.
    Bendok, Bernard R.
    Parney, Ian F.
    Chaichana, Kaisorn L.
    Swanson, Kristin R.
    Quinones-Hinojosa, Alfredo
    NEUROSURGERY, 2022, 68 : 46 - 46
  • [43] NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes
    Chang, Michael
    Sherief, Mohamed
    Ioannou, Maria
    Chinnasamy, Viveka
    Chen, Lucy
    Frost, Michael
    Mattson-Hoss, Michelle
    Sarnoff, Herb
    Kamson, David O.
    Holdhoff, Matthias
    Mukherjee, Debraj
    Bettegowda, Chetan
    Rincon-Torroella, Jordina
    Croog, Victoria
    Huang, Peng
    Rodriguez, Fausto J.
    Lucas, Calixto-Hope G.
    Schreck, Karisa C.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01):
  • [44] MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
    Ghimire, Prajwal
    Kamaludin, Ahmad
    Palau, Berta F.
    Lavrador, Jose P.
    Gullan, Richard
    Vergani, Francesco
    Bhangoo, Ranjeev
    Ashkan, Keyoumars
    ACTA NEUROCHIRURGICA, 2024, 166 (01)
  • [45] COMPARATIVE ANALYSIS OF DNA METHYLATION PROFILES ASSOCIATED WITH IDH-WILDTYPE GLIOMA AND GLIONEURONAL TUMOR SUBTYPES
    Singh, Omkar
    Aldape, Kenneth
    NEURO-ONCOLOGY, 2020, 22 : 170 - 170
  • [46] SAFE MAXIMAL RESECTION OF IDH-WILDTYPE GLIOBLASTOMA WITH TUMOR-FREE MOLECULAR MARGIN RESULTS IN PROLONGED PROGRESSION-FREE SURVIVAL
    Shankar, Ganesh
    Massaad, Elie
    Bradley, Joseph
    Lennerz, Jochen
    Dietrich, Jorg
    Choi, Bryan
    Nahed, Brian
    Curry, William
    Batchelor, Tracy
    Carter, Bob
    Cahill, Daniel
    NEURO-ONCOLOGY, 2022, 24 : 19 - 19
  • [47] Pre-operative mean platelet volume is associated with overall survival in patients with IDH-wildtype glioblastoma undergoing maximal safe resection
    Snider, Silvia
    De Domenico, Pierfrancesco
    Roncelli, Francesca
    Bisoglio, Andrea
    Braga, Matteo
    Ghelfi, Anna
    Barzaghi, Lina Raffaella
    Mura, Cinzia
    Mortini, Pietro
    Gagliardi, Filippo
    ONCOLOGY LETTERS, 2024, 28 (06)
  • [48] Prediction of O(6)-methylguanine-DNA methyltransferase promoter methylation status in IDH-wildtype glioblastoma using MRI histogram analysis
    Liu, Xianwang
    Han, Tao
    Wang, Yuzhu
    Liu, Hong
    Zhou, Junlin
    NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [49] A CASE SERIES OF LONGER THAN EXPECTED SURVIVAL IN IDH-WILDTYPE, MGMT-UNMETHYLATED GLIOBLASTOMA PATIENTS
    Lomax, Jerica
    Kong, Xiao-Tang
    Bota, Daniela
    NEURO-ONCOLOGY, 2023, 25
  • [50] Unlocking Bevacizumab's Potential: rCBVmax as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients
    Alvarez-Torres, Maria del Mar
    Balana, Carmen
    Fuster-Garcia, Elies
    Puig, Josep
    Garcia-Gomez, Juan Miguel
    CANCERS, 2024, 16 (01)
12345